Presumptive laws increasingly recognize conditions such as cancer, Post Traumatic Stress Disorder (PTSD), and respiratory, cardiac, and blood disorders as work related, removing the burden of proof from employees and placing new responsibilities on employers and payers. While these laws improve access to care, they also drive higher claim volumes, longer treatment durations, and increased medication utilization, making effective clinical oversight more critical than ever.
This one-hour educational webinar will examine how presumptive legislation is reshaping workers' compensation and why traditional injury-focused models are no longer sufficient. Attendees will gain practical insight into managing medications tied to long-term illness and disease, as well as understanding regulatory trends that are influencing claim strategy nationwide.
The session will feature Courtney Deck, RPh, Senior Manager of Clinical Account Executives at MyMatrixx by Evernorth, who will review common presumptive conditions and the medication therapies frequently associated with them. Adam Fowler, Director of Regulatory Affairs at MyMatrixx by Evernorth, will provide an overview of current and proposed state legislative actions impacting presumptive coverage and what claims professionals should be preparing for next (Next Aktie).
Designed for workers' compensation professionals, employers, and payers, the webinar aims to help organizations proactively adapt to the growing impact of presumptive coverage while balancing patient care, compliance, and cost control.
Event Details:
Title: Medication Management in Workers' Compensation Presumption Claims
Date: Tuesday, March 24, 2026
Time: 3:00 PM ET
Format: Live, one hour continuing education webinar
About MyMatrixx by Evernorth
MyMatrixx by Evernorth provides clinically driven pharmacy benefit management solutions for workers' compensation and specialty pharmacy programs, combining technology-enabled insights with pharmacist-led expertise to improve outcomes, enhance safety, and manage cost.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279362
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.